Elderly patients may require adjusted dosing due to decreased absorption efficiency
Hall KD, Sacks G, Chandramohan D, Chow CC, Wang YC, Gortmaker SL, et al
this should be considered by clinicians in any trial or supervised setting, in line with NICE guideline NG28 (Type 2 diabetes in adults)
This option is ideal for convenience and reducing preparation time
In this paper from 2009, N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study, it is reported that Fifty individuals with trichotillomania (45 women and 5 men) received 1200-2400 mg/day of N-acetylcysteine or placebo over a 12-week period